Initial Results From Emprise Realworld Evidence Study Shows Empagliflozin Was Associated With Reduced Risk For Hospitalisation For Heart Failure Compared With Dpp4 Inhibitors | Latest News RSS feed

FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us